共 142 条
[1]
Adeloye D(2015)Global and regional estimates of COPD prevalence: systematic review and meta-analysis J Glob Health. 5 020415-554
[2]
Chua S(2016)Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and meta-analysis Chest. 151 544-639
[3]
Lee C(2015)Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis Lancet Respir Med. 3 631-789
[4]
Aleva FE(2007)Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med. 356 775-415
[5]
Voets LW(2007)Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee Thorax. 62 411-793
[6]
Simons SO(2009)Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis Chest. 135 786-e27
[7]
de Mast Q(2015)An Official American Thoracic Society/European Respiratory Society Statement: research questions in chronic obstructive pulmonary disease Am J Respir Crit Care Med. 191 e4-931
[8]
van der Ven AJ(2005)Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Thorax. 60 925-998
[9]
Heijdra YF(2015)Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001–2012 and Nationwide Emergency Department Sample 2006–2011 Chest. 147 989-1097
[10]
Chen W(2010)Increased risk of myocardial infarction and stroke following exacerbation of COPD Chest. 137 1091-258